A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis

• Автори: Daniel J. Lovell (Автор), Jason A. Dare (Автор), Megan Francis-Sedlak (Автор), Julie Ball (Автор), Brian D. LaMoreaux (Автор), Emily Von Scheven (Автор), Adam Reinhardt (Автор), Rita Jerath (Автор), Oral Alpan (Автор), Ramesh Gupta (Автор), Donald Goldsmith (Автор), Andrew Zeft (Автор), Henry Naddaf (Автор), Beth Gottlieb (Автор), Lawrence Jung (Автор), Robert J. Holt (Автор)
• Формат: Книга
• Опубліковано: BMC, 2018-06-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

Abstract Background Juvenile idiopathic arthritis (JIA) is an inflammatory arthritis of unknown etiology, which lasts for greater than 6 weeks with onset before 16 years of age. JIA is the most common chronic rheumatic disease in children. NSAIDs have been the mainstay of initial management with nap...